Mattia Matasci

5PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 15, 2026
Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix-Targeted Radiopharmaceutical against Triple-Negative Breast Cancer.

Justin S Hachey, Tara D Viray, Sebastian E Carrasco

|Jul 03, 2023
A DNA-encoded chemical library based on chiral 4-amino-proline enables stereospecific isozyme-selective protein recognition.

Sebastian Oehler, Laura Lucaroni, Francesca Migliorini

|Nov 15, 2022
Targeted Interleukin-9 delivery in pulmonary hypertension: Comparison of immunocytokine formats and effector cell study.

Judith Heiss, Katja Grün, Laura Tempel

|Apr 25, 2022
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse.

Andrew F Berdel, Leo Ruhnke, Linus Angenendt

|Jan 21, 2021
Antibody-based delivery of interleukin-9 to neovascular structures: Therapeutic evaluation in cancer and arthritis.

Baptiste Gouyou, Tiziano Ongaro, Samuele Cazzamalli

Pageof 1

Frequent Collaborators

1 joint publications

Andrew F Berdel

1 joint publications

Linus Angenendt

1 joint publications

Martin Wermke

1 joint publications

Christoph Röllig